You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 298 No. 16, October 24/31, 2007 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related letter
 •Similar articles in JAMA
 Topic Collections
 •Public Health, Other
 •Bacterial Infections
 •Travel Medicine
 •Tuberculosis/ Other Mycobacterium
 •Alert me on articles by topic

Extensively Drug-Resistant Tuberculosis and Public Health—Reply

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In Reply: We disagree with Dr Brewer regarding his CDC classification of Andrew Speaker. The CDC has recently revised its tuberculosis screening protocols for immigrant visa applicants, emphasizing the importance of TB cultures in addition to acid-fast bacilli (AFB) smear microscopy. The Centers for Disease Control and Prevention's Division of Global Migration and Quarantine (DGMQ) and Division of Tuberculosis Elimination (DTE) have posted new TB technical instructions for overseas panel physicians performing screening examinations for individuals applying for permanent visas.1 These technical instructions have been revised over the past 2 years with the accretion of new scientific evidence documenting TB transmission from smear-negative, culture-positive patients and the continued emergence of drug-resistant TB (MDR and XDR).2-4

The new technical instructions classify an individual with Speaker's signs and symptoms as class A pulmonary TB (active and infectious), not as class B1, as Brewer states. Consequently, if a man presenting like Speaker were . . . [Full Text of this Article]

Howard Markel, MD, PhD
howard@umich.edu
Center for the History of Medicine
University of Michigan
Ann Arbor

Lawrence O. Gostin, JD
O’Neill Institute for National and Global Health Law
Georgetown University Law Center
Washington, DC

David P. Fidler, JD
Indiana University School of Law
Bloomington


RELATED LETTER

Extensively Drug-Resistant Tuberculosis and Public Health
Timothy Brewer
JAMA. 2007;298(16):1861.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.